SCHEMBL390797

SCHEMBL390797

CCN(CC)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C2O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.40
CYP3A4 P08684 4/20 0.40
MEN1 O00255 8/20 0.39
KMT2A Q03164 8/20 0.39
NPSR1 Q6W5P4 6/20 0.39
GAA P10253 4/20 0.39
HTT P42858 4/20 0.39
CASP1 P29466 4/20 0.39
CASP7 P55210 4/20 0.39
NPC1 O15118 3/20 0.39
TSHR P16473 3/20 0.39
USP2 O75604 3/20 0.39
CYP2C19 P33261 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
BRCA1 P38398 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 1/20 0.39
HBB P68871 1/20 0.39
MAPT P10636 8/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10020930 0.83 MAPT (0.44) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL391014 0.83 MAPT (0.44) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL8778047 0.81 NPSR1 (0.46) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL3896114 0.79 MEN1 (0.43) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL27979822 0.78 MEN1 (0.42) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL3895025 0.76 NPSR1 (0.40) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL11520111 0.75 MEN1 (0.48) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL16547109 0.75 TSHR (0.42) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL5010108 0.73 NPSR1 (0.41) ALDH1A1CYP3A4MEN1KMT2ANPSR1
SCHEMBL82135 0.73 MEN1 (0.52) ALDH1A1CYP3A4MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101655-B2 Fluorescent dyes and complexes SMITH GERALD ARTHUR (GB) 2012-01-24 US disclosed
US-8101655-B2 Fluorescent dyes and complexes SMITH GERALD ARTHUR (GB) 2012-01-24 US disclosed
US-20100256399-A1 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE ENTERPRISE LIMITED (GB) 2010-10-07 US disclosed
US-20100256399-A1 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE ENTERPRISE LIMITED (GB) 2010-10-07 US disclosed
US-7674918-B2 Fluorescent dyes and complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2010-03-09 US disclosed
US-7674918-B2 Fluorescent dyes and complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2010-03-09 US disclosed
US-7674918-B2 Fluorescent dyes and complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2010-03-09 US disclosed
US-20070238884-A1 Fluorescent Dyes and Complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-10-11 US disclosed
US-20070238884-A1 Fluorescent Dyes and Complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-10-11 US disclosed
US-20070238884-A1 Fluorescent Dyes and Complexes CAMBRIDGE ENTERPRISE LIMITED (GB) 2007-10-11 US disclosed
EP-1740947-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LIMITED (GB) 2007-01-10 EP disclosed
WO-2005098437-A2 FLUORESCENT DYES AND COMPLEXES CAMBRIDGE UNIVERSITY TECHNICAL SERVICES LTD (GB) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238884-A1 Fluorescent Dyes and Complexes F12, PYM1, ANXA6 ALDH1A1 1039/4885CYP3A4 438/4885MEN1 3023/4885
US-20100256399-A1 FLUORESCENT DYES AND COMPLEXES F12, ANXA6, PYM1 ALDH1A1 1468/4885CYP3A4 805/4885MEN1 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.